COX-2 inhibitor use increased after formulary listing in Canada

2002 ◽  
Vol 392 (1) ◽  
pp. 5-5
Keyword(s):  
Formulary Listing ◽  
Cox 2

COX-2 inhibitor use increased after formulary listing in Canada

2002 ◽  
Vol &NA; (1367) ◽  
pp. 7
Author(s):  
&NA;
Keyword(s):  
Formulary Listing ◽  
Cox 2

Significant reduction in serious upper gastrointestinal (UGI) events with celecoxib, a COX-2 specific inhibitor, compared with conventional NSAIDs. The SUCCESS I trial

2001 ◽  
Vol 120 (5) ◽  
pp. A105-A105
Author(s):  
J GOLDSTEIN ◽  
G EISEN ◽  
W STENSON ◽  
N AGRAWAL ◽  
A BELLO ◽  
...  
Keyword(s):  
Specific Inhibitor ◽  
Cox 2 ◽  
Upper Gastrointestinal

Contribution of stromal and epithelial cells to cyclooxygenase-2 (COX-2) activity in Barrett's esophagus

2001 ◽  
Vol 120 (5) ◽  
pp. A78-A79
Author(s):  
N BUTTAR ◽  
K WANG ◽  
M ANDERSON ◽  
L LUTZKE ◽  
K KRISHNADATH
Keyword(s):  
Epithelial Cells ◽  
Barrett’S Esophagus ◽  
Barrett's Esophagus ◽  
Cyclooxygenase 2 ◽  
Cox 2

Expressions of cyclooxygenase-2 (COX-2) and prostaglandin E receptors (EPs) in gallbladder carcinoma (GBca)-association with tumor progression

2001 ◽  
Vol 120 (5) ◽  
pp. A573-A573
Author(s):  
J SHODA ◽  
T ASANO ◽  
T KAWAMOTO ◽  
Y MATSUZAKI ◽  
N TANAKA ◽  
...  
Keyword(s):  
Tumor Progression ◽  
Gallbladder Carcinoma ◽  
Cyclooxygenase 2 ◽  
Prostaglandin E ◽  
Cox 2

Deoxycholic (DOC) acid-induced expression of cyclooxygenase-2 (COX-2) in human colonic fibroblasts

2001 ◽  
Vol 120 (5) ◽  
pp. A170-A170
Author(s):  
S RAFIQ ◽  
Y ZHU ◽  
P LANCE
Keyword(s):  
Cyclooxygenase 2 ◽  
Induced Expression ◽  
Cox 2

Treatment of peripheral arthropathy in IBD with rofecoxib, a selective COX-2 inhibitor

2001 ◽  
Vol 120 (5) ◽  
pp. A277-A277 ◽  
Author(s):  
W REINISCH ◽  
W MIEHSLER ◽  
C DEJACO ◽  
P GLAUNINGER ◽  
H VOGELSANG
Keyword(s):  
Cox 2

Induction of gastric lesions by cyclooxygenase (COX-2) inhibitors in the stomach of adjuvant-induced arthritic rats

2001 ◽  
Vol 120 (5) ◽  
pp. A143-A144
Author(s):  
S KATO ◽  
Y OGAWA ◽  
T KUNIKATA ◽  
T WATANABE ◽  
T ARAKAWA ◽  
...  
Keyword(s):  
Gastric Lesions ◽  
Cox 2 ◽  
Cox 2 Inhibitors

Gastrin and cyclooxygenase-2 (COX-2) expression in Helicobacter pylori (Hp) infected gastric ulceration

2001 ◽  
Vol 120 (5) ◽  
pp. A727-A727
Author(s):  
S KONTUREK ◽  
P KONTUREK ◽  
W BIELANSKI ◽  
A DUDA ◽  
M ZUCHOWICZ ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Gastric Ulceration ◽  
Cyclooxygenase 2 ◽  
Cox 2

602: COX-2 Inhibition: A Mechanism for Increasing the Efficacy of BCG Immunotherapy for Urothelial Carcinoma

2005 ◽  
Vol 173 (4S) ◽  
pp. 164-165
Author(s):  
Simon Dovedi ◽  
John A. Kirby ◽  
Helen Atkins ◽  
Barry R. Davies ◽  
John D. Kelly
Keyword(s):  
Urothelial Carcinoma ◽  
Bcg Immunotherapy ◽  
Cox 2

947: Chemopreventive Effects of COX-2 Inhibitor and Epidermal Growth Factor (EGF)-Receptor Kinase Inhibitor on Rat Urinary Bladder Tumorigenesis

2004 ◽  
Vol 171 (4S) ◽  
pp. 251-251
Author(s):  
Kazunori Hattori ◽  
Katsuyuki Iida ◽  
Akira Johraku ◽  
Sadamu Tsukamoto ◽  
Taeko Asano ◽  
...  
Keyword(s):  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Urinary Bladder ◽  
Egf Receptor ◽  
Kinase Inhibitor ◽  
Receptor Kinase ◽  
Rat Urinary Bladder ◽  
Epidermal Growth ◽  
Cox 2
Sign in / Sign up

Export Citation Format

Share Document